Biomarkers derived from routine blood work—such as the Systemic Immune-Inflammation Index (SII), the Neutrophil Percentage to Albumin Ratio (NPAR), or the monocyte-to-lymphocyte ratio (MLR)—are widely used to gauge systemic inflammation and predict chronic disease risk. The underlying assumption behind these tools is straightforward: higher circulating levels of inflammatory cells correlate with a higher risk of tissue pathology.
However, a growing body of clinical evidence reveals that this relationship is fundamentally dimorphic, splitting sharply along the lines of biological sex. A universal inflammatory score can highly accurately predict a disease in men while completely failing to do so in women, or vice versa. To understand why these universal diagnostic tools break down, we must look at how sex hormones act as powerful immunomodulators that mask, suppress, or non-linearly accelerate inflammatory pathways.
The Masking Effect of Estrogen
Why do universal inflammatory indices fail to predict risk equally across sexes? The answer lies primarily in the immunomodulatory power of estrogen. Estrogen acts as a potent regulator of immune cell transcription and cytokine production. It can actively suppress or alter inflammatory pathways, effectively decoupling circulating immune cell ratios from actual downstream tissue damage.
Consider the prediction of kidney stones. As demonstrated by Yan Zhou et al. in The advanced lung cancer inflammation index as a predictor of kidney stone risk in men, the Advanced Lung Cancer Inflammation Index (ALI) serves as a strong predictor of kidney stone risk in male cohorts. In women, however, the index loses its predictive utility. The authors suggest that estrogen's natural anti-inflammatory properties mask the underlying inflammatory pathways that contribute to stone formation, rendering the unadjusted index ineffective for female patients.
A similar pattern emerges in vascular health. In The Leukocyte Subtype Counts and Ratios Can Effectively Predict the Risk of Arterial Stiffness Assessed by Cardio-Ankle Vascular Index, Yaolin Wang et al. established that the monocyte-to-lymphocyte ratio (MLR) predicts arterial stiffness with high accuracy in men, but exhibits significantly lower predictive utility in women. Here again, the anti-inflammatory properties of estrogen modulate the relationship between systemic inflammation and vascular aging, obscuring the physical pathology that a simple blood count would normally reveal.
Non-Linear Trajectories and Hormonal Tipping Points
Because hormone levels fluctuate across a lifespan, sex-dimorphic disease progression rarely follows a simple linear path. Instead, it is punctuated by major hormonal transitions—namely, puberty and menopause—which completely rewrite the rules of how inflammation manifests physically.
During youth, the onset of puberty triggers a dramatic realignment of chronic risks. In an individual participant meta-analysis of five birth cohorts (Sex-specific incidence of asthma, rhinitis and respiratory multimorbidity before and after puberty onset), Cynthia Hohmann et al. observed a distinct "sex shift" in respiratory diseases. While boys face a significantly higher incidence of asthma and rhinitis during childhood, the risk balances out or tilts toward girls once puberty begins, demonstrating that the sudden influx of sex hormones fundamentally alters airway pathophysiology.
Later in life, the onset of menopause removes estrogen's protective shield, causing a non-linear acceleration in cardiovascular and inflammatory diseases. Xinnian Yang et al. mapped this phenomenon in Deciphering age- and sex-specific patterns of coronary artery atherosclerosis from a large Chinese cohort. The authors discovered a striking 20-year delay in the onset of coronary atherosclerosis for women compared to men. While male plaque accumulation climbs linearly with age, female plaque accumulation undergoes a sharp, non-linear acceleration that directly coincides with menopause.
Linear Progression (Typical Male Trajectory)
Inflammation/Plaque Risk ───► Linear increase with age
Non-Linear Shift (Typical Female Trajectory)
Inflammation/Plaque Risk ───► Protected (Pre-menopause) ───► Sharp Acceleration (Post-menopause)
This temporal vulnerability window is further supported by research into heart inflammation. In Clinical features, myocardial injury and systolic impairment in acute myocarditis, Vijay Shyam-Sundar et al. found that while men generally experience more extensive tissue damage from acute myocarditis, women display a distinct bimodal age distribution of onset, pointing to menopausal hormonal shifts as a key variable influencing susceptibility to inflammatory heart disease.
Divergent Outcomes from Shared Inflammation
Even when men and women exhibit identical levels of systemic inflammation, the resulting pathological outcomes can diverge completely. The same inflammatory profile can trigger entirely different organ vulnerabilities depending on biological sex.
For instance, the Systemic Immune-Inflammation Index (SII) yields opposite predictive values for cataracts and strokes depending on sex:
- In Women: Jin Huang et al. demonstrated in Association between systemic immune-inflammation index and cataract among outpatient US adults that elevated SII scores are significantly associated with an increased risk of cataracts in women, but show no such correlation in men.
- In Men: Conversely, in Systemic Immune-Inflammation Index and Its Association with the Prevalence of Stroke in the United States Population, Guangcheng Liu et al. found that the association between high SII and stroke prevalence is heavily modulated by sex, with male populations showing a far more pronounced sensitivity to high inflammatory markers.
The mathematical shape of the risk itself can also change. In Association between neutrophil percentage to albumin ratio and cardiovascular disease in the metabolic syndrome population, Chengjun Li et al. showed that the relationship between NPAR and cardiovascular disease varies by sex, manifesting as a steady linear progression in one group and a non-linear "tipping point" threshold effect in another.
Alternative Hormonal Pathways
While estrogen's anti-inflammatory properties explain much of this divergence, other hormonal mechanisms drive sex-specific disease pathways. For example, metabolic inflammation can be mediated by androgens rather than estrogens in female populations. In a two-step Mendelian randomization study (Relationship of obesity, body fat, benign adrenal tumors and the mediating mechanism), Qiwei Wang et al. proved that the causal chain linking obesity to benign adrenal tumors is heavily driven by elevated levels of total and bioavailable testosterone in women—a biological mediation pathway that is entirely absent in men.
Furthermore, hormonal fluctuations can actively provoke localized inflammation in the central nervous system. In Global trends in migraine and anxiety over the past 10 years: a bibliometric analysis, Biao Huang et al. highlighted emerging research showing that cyclical estrogen fluctuations can directly activate inflammatory pathways within the hippocampus, providing a clear biological mechanism for why women experience a disproportionately higher rate of comorbid migraine and anxiety.
Ultimately, these findings demonstrate that systemic inflammation does not operate in a vacuum. Because sex hormones constantly modulate immune cell behavior, mask inflammatory pathways, and alter tissue vulnerability, clinical models must move away from universal biomarker thresholds and toward sex-stratified diagnostic indices.
Key Foundational Work
Association between investigator-measured body-mass index and colorectal adenoma: a systematic review and meta-analysis of 168,201 subjects (2017) — contributed 1 concept elements to this direction.
Both low and high serum ferritin levels predict mortality risk in hemodialysis patients without inflammation (2016) — contributed 1 concept elements to this direction.